Logo image of TNON

TENON MEDICAL INC (TNON) Stock Earnings & Estimates

NASDAQ:TNON - US88066N3035 - Common Stock

1.39 USD
-0.1 (-6.71%)
Last: 8/25/2025, 8:00:01 PM
1.4 USD
+0.01 (+0.72%)
Pre-Market: 8/26/2025, 6:45:29 AM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
TNON revenue by date.TNON revenue by date.
690K
331.25%
2.928M
324.35%
3.277M
11.92%
4.703M
43.52%
8.566M
82.14%
16.945M
97.82%
22.564M
33.16%
36.451M
61.54%
49.208M
35.00%
EBITDA
YoY % growth
TNON ebitda by date.TNON ebitda by date.
-18.65M
-188.70%
-15.301M
17.96%
-13.111M
14.31%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
TNON ebit by date.TNON ebit by date.
-18.73M
-189.94%
-15.727M
16.03%
-13.766M
12.47%
-14.33M
-4.10%
-13.556M
5.41%
-13.318M
1.75%
-6.908M
48.13%
-1.34M
80.60%
7.353M
648.62%
Operating Margin
TNON operating margin by date.TNON operating margin by date.
-2,714.49%-537.12%-420.08%-304.71%-158.25%-78.60%-30.62%-3.68%14.94%
EPS
YoY % growth
TNON eps by date.TNON eps by date.
N/A-77.92
59.71%
-24.33
68.78%
-1.85
92.39%
-0.92
50.41%
-0.51
44.44%
-0.31
40.00%
-0.05
83.33%
0.20
500.00%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.41
88.76%
-0.34
86.75%
Revenue
Q2Q % growth
1.394M
57.16%
1.813M
135.45%
EBITDA
Q2Q % growth
N/AN/A
EBIT
Q2Q % growth
-3.359M
-4.47%
-3.261M
-2.79%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.36
95.59%
-0.480.1224.91%
Q1 2025
Q2Q % growth
-1.01
89.90%
-1.130.1210.79%
Q4 2024
Q2Q % growth
-2.54
53.31%
-2.590.051.96%
Q3 2024
Q2Q % growth
-3.63
68.92%
-4.320.6915.97%
Q2 2024
Q2Q % growth
-8.16
69.09%
-8.850.697.83%
Q1 2024
Q2Q % growth
-10.00
70.93%
-10.930.938.55%
Q4 2023
Q2Q % growth
-5.44
90.29%
-11.265.8251.69%
Q3 2023
Q2Q % growth
-11.68
47.86%
-22.8511.1748.88%
Q2 2023
Q2Q % growth
-26.40
49.23%
-31.014.6114.86%
Q1 2023
Q2Q % growth
-34.40 -30.19-4.21-13.94%
Q4 2022
Q2Q % growth
-56.00 -57.121.121.96%
Q3 2022
Q2Q % growth
-22.40 -38.3515.9541.59%
Q2 2022
Q2Q % growth
-52.00 -16.32-35.68-218.63%
TNON Yearly EPS VS EstimatesTNON Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -50 -100 -150
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
564K
-37.40%
927.69K-363.69K-39.20%
Q1 2025
Q2Q % growth
726K
0.97%
1.223M-497K-40.64%
Q4 2024
Q2Q % growth
770K
-4.70%
1.48M-710K-47.97%
Q3 2024
Q2Q % growth
887K
-6.04%
1.214M-327K-26.94%
Q2 2024
Q2Q % growth
901K
21.27%
927.69K-26.69K-2.88%
Q1 2024
Q2Q % growth
719K
66.05%
798.66K-79.66K-9.97%
Q4 2023
Q2Q % growth
808K
188.57%
1.084M-276K-25.46%
Q3 2023
Q2Q % growth
944K
349.52%
1.093M-149K-13.63%
Q2 2023
Q2Q % growth
743K
430.71%
1.02M-277K-27.16%
Q1 2023
Q2Q % growth
433K
518.57%
467.16K-34.16K-7.31%
Q4 2022
Q2Q % growth
280K
460.00%
282.54K-2.54K-0.90%
Q3 2022
Q2Q % growth
210K
200.00%
289.68K-79.68K-27.51%
Q2 2022
Q2Q % growth
140K
275.34%
144.84K-4.84K-3.34%
Q4 2021
Q2Q % growth
50K
400.00%
%
TNON Yearly Revenue VS EstimatesTNON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M 40M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS8.05% 75.76% 7.63% 32.53%
Revenue7.48% -24.93% 3.23% -24.82%